Cargando…
Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies
BACKGROUND: In a subgroup of patients with mood disorders, clear-cut organic disorders are responsible for depressive symptoms (e.g., autoimmune diseases such as multiple sclerosis or systemic lupus erythematosus). In these cases, an organic affective disorder can be diagnosed. CASE PRESENTATION: Th...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457046/ https://www.ncbi.nlm.nih.gov/pubmed/32922313 http://dx.doi.org/10.3389/fpsyt.2020.00745 |
_version_ | 1783575922422579200 |
---|---|
author | Endres, Dominique Rauer, Sebastian Venhoff, Nils Süß, Patrick Dersch, Rick Runge, Kimon Fiebich, Bernd L. Nickel, Kathrin Matysik, Miriam Maier, Simon Domschke, Katharina Egger, Karl Prüss, Harald van Elst, Ludger Tebartz |
author_facet | Endres, Dominique Rauer, Sebastian Venhoff, Nils Süß, Patrick Dersch, Rick Runge, Kimon Fiebich, Bernd L. Nickel, Kathrin Matysik, Miriam Maier, Simon Domschke, Katharina Egger, Karl Prüss, Harald van Elst, Ludger Tebartz |
author_sort | Endres, Dominique |
collection | PubMed |
description | BACKGROUND: In a subgroup of patients with mood disorders, clear-cut organic disorders are responsible for depressive symptoms (e.g., autoimmune diseases such as multiple sclerosis or systemic lupus erythematosus). In these cases, an organic affective disorder can be diagnosed. CASE PRESENTATION: The authors present the case of a 59-year-old male patient who developed a severe depressive episode over approximately 6 months and was, therefore, admitted to the hospital. In retrospect, he reported that, at age 39, he suffered from self-limiting sensory disturbances and muscle weakness in both legs. The current magnetic resonance imaging of his brain showed several conspicuous FLAIR-hyperintense supratentorial white matter lesions compatible with chronic inflammatory brain disease. Imaging of the spinal axis revealed no clear spinal lesions. Cerebrospinal fluid (CSF) analyses showed CSF-specific oligoclonal bands. Therefore, multiple sclerosis was diagnosed. Further CSF analyses, using tissue-based assays with indirect immunofluorescence on unfixed murine brain tissue, revealed a (peri-)nuclear signal and a strong neuritic signal of many neurons, especially on granule cells in the cerebellum, hippocampus, and olfactory bulb, as well as in the corpus callosum. Additionally, antinuclear antibody (ANA) titers of 1:12,800 and a lymphopenia were detected in blood tests. Further system clarification showed no suspicion of rheumatic or oncological disease. Anti-inflammatory treatment led to rapid and sustained improvement. CONCLUSION: The present patient suffered from a probable “autoimmune depression” in the context of newly diagnosed multiple sclerosis with typical MRI and CSF pathologies, alongside mild concomitant latent systemic autoimmune process (with high-titer ANAs and lymphopenia) and unknown antineuronal antibodies. The case report illustrates that a depressive syndrome suggestive of primary idiopathic depressive disorder may be associated with an autoimmune brain involvement. The detection of such organic affective disorders is of high clinical relevance for affected patients, as it enables alternative and more causal treatment approaches. |
format | Online Article Text |
id | pubmed-7457046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74570462020-09-11 Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies Endres, Dominique Rauer, Sebastian Venhoff, Nils Süß, Patrick Dersch, Rick Runge, Kimon Fiebich, Bernd L. Nickel, Kathrin Matysik, Miriam Maier, Simon Domschke, Katharina Egger, Karl Prüss, Harald van Elst, Ludger Tebartz Front Psychiatry Psychiatry BACKGROUND: In a subgroup of patients with mood disorders, clear-cut organic disorders are responsible for depressive symptoms (e.g., autoimmune diseases such as multiple sclerosis or systemic lupus erythematosus). In these cases, an organic affective disorder can be diagnosed. CASE PRESENTATION: The authors present the case of a 59-year-old male patient who developed a severe depressive episode over approximately 6 months and was, therefore, admitted to the hospital. In retrospect, he reported that, at age 39, he suffered from self-limiting sensory disturbances and muscle weakness in both legs. The current magnetic resonance imaging of his brain showed several conspicuous FLAIR-hyperintense supratentorial white matter lesions compatible with chronic inflammatory brain disease. Imaging of the spinal axis revealed no clear spinal lesions. Cerebrospinal fluid (CSF) analyses showed CSF-specific oligoclonal bands. Therefore, multiple sclerosis was diagnosed. Further CSF analyses, using tissue-based assays with indirect immunofluorescence on unfixed murine brain tissue, revealed a (peri-)nuclear signal and a strong neuritic signal of many neurons, especially on granule cells in the cerebellum, hippocampus, and olfactory bulb, as well as in the corpus callosum. Additionally, antinuclear antibody (ANA) titers of 1:12,800 and a lymphopenia were detected in blood tests. Further system clarification showed no suspicion of rheumatic or oncological disease. Anti-inflammatory treatment led to rapid and sustained improvement. CONCLUSION: The present patient suffered from a probable “autoimmune depression” in the context of newly diagnosed multiple sclerosis with typical MRI and CSF pathologies, alongside mild concomitant latent systemic autoimmune process (with high-titer ANAs and lymphopenia) and unknown antineuronal antibodies. The case report illustrates that a depressive syndrome suggestive of primary idiopathic depressive disorder may be associated with an autoimmune brain involvement. The detection of such organic affective disorders is of high clinical relevance for affected patients, as it enables alternative and more causal treatment approaches. Frontiers Media S.A. 2020-08-13 /pmc/articles/PMC7457046/ /pubmed/32922313 http://dx.doi.org/10.3389/fpsyt.2020.00745 Text en Copyright © 2020 Endres, Rauer, Venhoff, Süß, Dersch, Runge, Fiebich, Nickel, Matysik, Maier, Domschke, Egger, Prüss and van Elst http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Endres, Dominique Rauer, Sebastian Venhoff, Nils Süß, Patrick Dersch, Rick Runge, Kimon Fiebich, Bernd L. Nickel, Kathrin Matysik, Miriam Maier, Simon Domschke, Katharina Egger, Karl Prüss, Harald van Elst, Ludger Tebartz Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title | Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title_full | Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title_fullStr | Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title_full_unstemmed | Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title_short | Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies |
title_sort | probable autoimmune depression in a patient with multiple sclerosis and antineuronal antibodies |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457046/ https://www.ncbi.nlm.nih.gov/pubmed/32922313 http://dx.doi.org/10.3389/fpsyt.2020.00745 |
work_keys_str_mv | AT endresdominique probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT rauersebastian probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT venhoffnils probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT sußpatrick probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT derschrick probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT rungekimon probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT fiebichberndl probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT nickelkathrin probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT matysikmiriam probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT maiersimon probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT domschkekatharina probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT eggerkarl probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT prussharald probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies AT vanelstludgertebartz probableautoimmunedepressioninapatientwithmultiplesclerosisandantineuronalantibodies |